Thymon, LLC

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thymon, LLC.The latest application filed is for "compositions for selective reduction of circulating bioactive soluble tnf and methods for treating tnf-mediated disease".

Company Profile

0.8.14

Thymon, LLC - New York NY US
THYMON, LLC - Short Hills NJ
Thymon L.L.C. - Short Hills NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions For Selective Reduction Of Circulating Bioactive Soluble Tnf And Methods For Treating Tnf-mediated Disease App 20170190768 - Goldstein; Gideon	2017-07-06
Compositions for selective reduction of circulating bioactive soluble TNF and methods for treating TNF-mediated disease Grant 9,580,502 - Goldstein February 28, 2	2017-02-28
Compositions For Selective Reduction Of Circulating Bioactive Soluble Tnf And Methods For Treating Tnf-mediated Disease App 20160272705 - Goldstein; Gideon	2016-09-22
Compositions for selective reduction of circulating bioactive soluble TNF and methods for treating TNF-mediated disease Grant 9,388,240 - Goldstein July 12, 2	2016-07-12
Immunogenic and Prophylactic Compositions, Methods of Making Same, and Methods for Treating and Preventing TNF-Mediated Disease App 20150225478 - Goldstein; Gideon	2015-08-13
Compositions for Selective Reduction of Circulating Bioactive Soluble TNF and Methods for Treating TNF-Mediated Disease App 20150225477 - Goldstein; Gideon	2015-08-13
Compositions and Methods for the Treatment and Prophylaxis of Multiple Strains and Subtypes of HIV-1 App 20110189216 - Goldstein; Gideon	2011-08-04
Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of HIV-1 Grant 7,943,140 - Goldstein May 17, 2	2011-05-17
Methods and compositions for impairing multiplication of HIV-1 Grant 7,563,437 - Carlsson , et al. July 21, 2	2009-07-21
Compositions and methods for the treatment and prophylaxis of Alzheimer's disease App 20090123488 - Goldstein; Gideon	2009-05-14
Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of HIV-1 App 20090092626 - Goldstein; Gideon	2009-04-09
Assays for Detecting Hiv-1 Tat Protein in Hiv-1 Infection App 20080280305 - Goldstein; Gideon	2008-11-13
Methods and compositions for impairing multiplication of HIV-1 App 20060258594 - Goldstein; Gideon	2006-11-16
Methods and compositions for impairing multiplication of HIV-1 App 20060211108 - Carlsson; Roland ; et al.	2006-09-21
Methods and compositions for impairing multiplication of HIV-1 Grant 7,008,622 - Goldstein March 7, 2	2006-03-07
Methods and compositions for impairing multiplication of HIV-1 App 20030194408 - Goldstein, Gideon	2003-10-16
Methods and compositions for impairing multiplication of HIV-1 App 20030180326 - Goldstein, Gideon	2003-09-25
Methods and compositions for impairing multiplication of HIV-1 App 20030166832 - Goldstein, Gideon	2003-09-04
Methods and compositions for impairing multiplication of HIV-1 Grant 6,524,582 - Goldstein February 25, 2	2003-02-25
Methods and compositions for impairing multiplication of HIV-1 App 20020192232 - Goldstein, Gideon	2002-12-19

Company Registrations

NCAGE Code	4TSK4	THYMON LLC
CAGE Code	4TSK4	THYMON LLC

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.